Trigger point injection with 1% lidocaine for Facial Pain
Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department
See full descriptionAbout the trial for Facial Pain
Treatment Groups
This trial involves 2 different treatments. Trigger Point Injection With 1% Lidocaine is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.
Eligibility
This trial is for patients born any sex aged 18 and older. There are 2 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Trigger point injection with 1% lidocaine will improve 1 primary outcome and 3 secondary outcomes in patients with Facial Pain. Measurement will happen over the course of From initiation of the study up to the point the patient is discharged from the emergency department.
Patient Q & A Section
What are common treatments for facial pain?
Facial pain is a common chronic complaint and can affect the quality of life of an individual. Treatment is typically symptom-based, with a focus on pain and avoiding exacerbating conditions. The American Dental Association lists common treatments for facial pain and their effectiveness. If oral medication, dental procedures and other non-invasive techniques are not effective, more invasive, non-specific procedures may be helpful.\n
What is facial pain?
Facial pain is common (about 45% in this survey) but its underlying cause is not always identifiable. Painful temporomandibular joint may be one of its cause; it is likely common in bruxism. Pain in lower facial and neck area is more likely due to cervical spondylosis. Pain in the upper facial region is more likely due to degenerative nasolacrimal duct blockage.
What causes facial pain?
This review suggests that facial pain is the most common symptom of the chronic inflammatory process that causes a condition now called giant cell arteritis. Symptoms other than headache can be used to help establish the diagnosis.
Can facial pain be cured?
Treatment for facial pain must be based on a patient's history and physical examination to identify any other pathology. The nature of a sore or muscle trigger can help to direct treatment. A muscle trigger of facial pain may require surgical division. Triggers are best treated with a combination of NSAIDs and paracetamol (acetaminophen).
How many people get facial pain a year in the United States?
Around 2.5 million people in the United States will have facial pain in 2019. More than half a million will be under 50 years old.
What are the signs of facial pain?
A history of previous head or neck trauma and symptoms of facial nerve dysfunction, including a sense of weakness of a side of the face, decreased movement of a tongue, and weakness or numbness of an affected muscle are some of the signs of facial pain. Most importantly, facial pain can be a physical manifestation of psychological issues, such as PTSD or anxiety. The treatment of facial pain and associated symptoms should be done in collaboration with a psychiatrist and a plastic surgeon.
What is the latest research for facial pain?
Clinical research guidelines have been developed in the past decade, but most of the recent studies have included less people. Additional research, using larger sample sizes, is needed. To provide evidence-based care, healthcare providers should incorporate clinical research, not only based on research to guide decision making, but the latest research with the largest population of people possible.
Has trigger point injection with 1% lidocaine proven to be more effective than a placebo?
For people with chronic non-infective facial pain, the 1% lidocaine and 0.4% methylprednisolone injections showed a significant benefit for pain and tender point detection, but there was very low incidence of numbness.
What is the average age someone gets facial pain?
The average reported age of facial pain diagnosis is 55 with a wide age distribution and is greater than in the general population. In the United States, there is no national mean reported age of diagnosing facial pain among adults.
How does trigger point injection with 1% lidocaine work?
A trigger point injection in addition to the routine injections in the same spot is as effective as the routine injection in reducing pain and improving function at immediate and short-term followup.
Have there been other clinical trials involving trigger point injection with 1% lidocaine?
These data suggest that TRM is rare and most commonly related to adverse events and is often less than 1% for both a single TR and multiple TRs (2 or more) injection. TRM is not due solely to injection.
Does facial pain run in families?
In a recent study, findings of this study do not support the occurrence of facial pain as an inherited trait. In a recent study, findings support the contention that facial pain may have a psychological and non-genetic origin.